Skip to Main content Skip to Navigation
Journal articles

The safety profile of favipiravir should not be the first argument to suspend its evaluation in viral hemorrhagic fevers

Complete list of metadata

Cited literature [16 references]  Display  Hide  Download

https://www.hal.inserm.fr/inserm-02910920
Contributor : Myriam Bodescot Connect in order to contact the contributor
Submitted on : Monday, August 3, 2020 - 12:13:28 PM
Last modification on : Wednesday, September 28, 2022 - 8:30:25 AM
Long-term archiving on: : Monday, November 30, 2020 - 1:35:56 PM

File

journal.pntd.0008259.pdf
Publication funded by an institution

Identifiers

Citation

Denis Malvy, Anne-Marie Taburet, Xavier de Lamballerie, France Mentré, Fabrice Extramiana. The safety profile of favipiravir should not be the first argument to suspend its evaluation in viral hemorrhagic fevers. PLoS Neglected Tropical Diseases, Public Library of Science, 2020, 14 (6), pp.e0008259. ⟨10.1371/journal.pntd.0008259⟩. ⟨inserm-02910920⟩

Share

Metrics

Record views

82

Files downloads

239